NIPH Clinical Trials Search

JAPANESE
国立保健医療科学院
UMIN ID: C000000360

Registered date:01/06/2006

A randomized controlled trial to evaluate the effectiveness of adjuvant chemotherapy using FOLFOX to prevent recurrence after curative radiofrequency ablation of liver metastasis from colorectal carcinoma

Basic Information

Recruitment status Complete: follow-up complete
Health condition(s) or Problem(s) studiedCases with liver metastasis from colorectal carcinoma, which is removed curatively by radiofrequency ablation
Date of first enrollment2006/04/01
Target sample size190
Countries of recruitmentJapan
Study typeInterventional
Intervention(s)Parenterally administration of mFOLFOX6 for 12 courses after curative radoiofrequency ablation of liver metastasis from colorectal carcinoma Only follow-up without any anti-cancer therapy after curative radiofrequency ablation of liver metastasis from colorectal carcinoma

Outcome(s)

Primary OutcomeLiver metastasis disease-free survival
Secondary OutcomeDisease-free survival Overall survival Side effect

Key inclusion & exclusion criteria

Age minimum20years-old
Age maximumNot applicable
GenderMale and Female
Include criteria
Exclude criteriaThe patients with other malignant disease, non-curative radiofrequency ablation

Related Information

Contact

public contact
Name
Address 7-3-1, Hongo, Bunkyo-ku, Tokyo Japan
Telephone 03-3815-5411
E-mail
Affiliation Tokyo University Hospital Deoartment of gastroenterology
scientific contact
Name Masao Omata
Address 7-3-1, Hongo, Bunkyo-ku, Tokyo Japan
Telephone 03-3815-5411
E-mail
Affiliation Tokyo University Hospital Deoartment of gastroenterology